148 related articles for article (PubMed ID: 30713070)
1. A Hierarchical Regulatory Landscape during the Multiple Stages of EMT.
Meyer-Schaller N; Cardner M; Diepenbruck M; Saxena M; Tiede S; Lüönd F; Ivanek R; Beerenwinkel N; Christofori G
Dev Cell; 2019 Feb; 48(4):539-553.e6. PubMed ID: 30713070
[TBL] [Abstract][Full Text] [Related]
2. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
[TBL] [Abstract][Full Text] [Related]
3. Inferring microRNA and transcription factor regulatory networks in heterogeneous data.
Le TD; Liu L; Liu B; Tsykin A; Goodall GJ; Satou K; Li J
BMC Bioinformatics; 2013 Mar; 14():92. PubMed ID: 23497388
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs-143 and -145 induce epithelial to mesenchymal transition and modulate the expression of junction proteins.
Avalle L; Incarnato D; Savino A; Gai M; Marino F; Pensa S; Barbieri I; Stadler MB; Provero P; Oliviero S; Poli V
Cell Death Differ; 2017 Oct; 24(10):1750-1760. PubMed ID: 28644441
[TBL] [Abstract][Full Text] [Related]
6. Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer.
Kaller M; Hermeking H
Adv Exp Med Biol; 2016; 937():71-92. PubMed ID: 27573895
[TBL] [Abstract][Full Text] [Related]
7. Sub-circuits of a gene regulatory network control a developmental epithelial-mesenchymal transition.
Saunders LR; McClay DR
Development; 2014 Apr; 141(7):1503-13. PubMed ID: 24598159
[TBL] [Abstract][Full Text] [Related]
8. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
9. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
10. ERK signalling modulates epigenome to drive epithelial to mesenchymal transition.
Navandar M; Garding A; Sahu SK; Pataskar A; Schick S; Tiwari VK
Oncotarget; 2017 Apr; 8(17):29269-29281. PubMed ID: 28418928
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
Koutsaki M; Spandidos DA; Zaravinos A
Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
[TBL] [Abstract][Full Text] [Related]
12. Regulation of mesenchymal phenotype by MicroRNAs in cancer.
Yan J; Gumireddy K; Li A; Huang Q
Curr Cancer Drug Targets; 2013 Nov; 13(9):930-4. PubMed ID: 24168190
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs as critical regulators involved in regulating epithelial- mesenchymal transition.
Zhao X; Lu Y; Nie Y; Fan D
Curr Cancer Drug Targets; 2013 Nov; 13(9):935-44. PubMed ID: 24168189
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
[TBL] [Abstract][Full Text] [Related]
15. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
[TBL] [Abstract][Full Text] [Related]
16. Extensive transcriptional responses are co-ordinated by microRNAs as revealed by Exon-Intron Split Analysis (EISA).
Pillman KA; Scheer KG; Hackett-Jones E; Saunders K; Bert AG; Toubia J; Whitfield HJ; Sapkota S; Sourdin L; Pham H; Le TD; Cursons J; Davis MJ; Gregory PA; Goodall GJ; Bracken CP
Nucleic Acids Res; 2019 Sep; 47(16):8606-8619. PubMed ID: 31372646
[TBL] [Abstract][Full Text] [Related]
17. Comparative gene co-expression network analysis of epithelial to mesenchymal transition reveals lung cancer progression stages.
Wang D; Haley JD; Thompson P
BMC Cancer; 2017 Dec; 17(1):830. PubMed ID: 29212455
[TBL] [Abstract][Full Text] [Related]
18. Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism.
Mikaelian I; Malek M; Gadet R; Viallet J; Garcia A; Girard-Gagnepain A; Hesling C; Gillet G; Gonzalo P; Rimokh R; Billaud M
Cancer Res; 2013 Nov; 73(22):6621-31. PubMed ID: 24078802
[TBL] [Abstract][Full Text] [Related]
19. Stability of the hybrid epithelial/mesenchymal phenotype.
Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
[TBL] [Abstract][Full Text] [Related]
20. Epithelial mesenchymal transition Transcription Factor (TF): The structure, function and microRNA feedback loop.
Alidadiani N; Ghaderi S; Dilaver N; Bakhshamin S; Bayat M
Gene; 2018 Oct; 674():115-120. PubMed ID: 29936265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
